← All trials
NCT06188520
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 5, 2023
- Primary completion
- Jun 18, 2025
- Completion date
- Jun 18, 2025
- First posted
- Jan 3, 2024
- Last posted
- Oct 3, 2024
- Enrollment
- 204
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- AstraZenecaLead sponsor
- University of CambridgeOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.